Company Profile For King Pharmaceuticals, Inc.

King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products. It operates in four segments: branded prescription pharmaceuticals business, animal health business, Meridian auto-injector business and royalties. The Company’s wholly owned subsidiaries include Alpharma Inc., Meridian Medical Technologies, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development, Inc., Parkedale Pharmaceuticals, Inc. and Monarch Pharmaceuticals Ireland Limited. The Company markets its branded prescription pharmaceutical products to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons and hospitals across the United States and in Puerto Rico. On December 29, 2008, King Pharmaceuticals, Inc. acquired Alpharma Inc.

BRIEF: For the nine months ended 30 September 2009, King Pharmaceuticals, Inc.'s revenues increased 10% to $1.34B. Net income decreased 67% to $69.7M. Revenues reflect an increase in income from Meridian Auto-Injector and the presence of revenue from Animal Health segment. Net income was offset by increased cost of revenues, higher selling, general & administrative expenses and the presence of acquisition related costs.

King Pharmaceuticals, Inc.
501 Fifth Street
Bristol   TN   37620
P: +1423.9898000
F: +1423.2748677

3381